EU-Authorised Pertussis-Only Booster Vaccine for Healthcare Professionals

Healthcare professionals are among the population groups with increased potential exposure to pertussis. In many healthcare settings, booster vaccination is recommended at regular intervals to help maintain protection and reduce the risk of transmission to patients, colleagues, and other vulnerable individuals. BioNet has developed an EU-authorised pertussis-only booster vaccine that provides a targeted option which may align with occupational exposure patterns in healthcare environments.

Historically, healthcare professionals requiring pertussis boosters have relied on combination vaccines containing tetanus and diphtheria components, even when protection against those diseases did not require updating. The availability of a pertussis-only vaccine developed by BioNet offers an alternative approach, enabling booster vaccination focused specifically on pertussis, without additional antigens.

This option may support a more precise approach to occupational immunisation policies, allowing vaccination strategies to be adapted based on exposure risk, immunisation history, and clinical guidance, while remaining consistent with national recommendations and regulatory frameworks.
For healthcare institutions, the availability of an EU-authorised, targeted pertussis-only booster may contribute to greater flexibility in vaccination scheduling and policy planning, while remaining aligned with established clinical and regulatory standards.

BioNet’s EU-authorised pertussis-only booster expands the range of available vaccination options for healthcare professionals, supporting ongoing efforts to reduce disease transmission and maintain safe healthcare environments.

Read the full news: VacPertagen Receives EU Approval